Earnings
CVS
64.93
-0.60%
-0.39
Currencies: USD
Items
Total Revenue
Revenue
Other Revenue, Total
Cost of Revenue, Total
Gross Profit
Operating Expense
Selling/General/Admin.Expenses,Total
Research & Development
Depreciation/Amortization
Interest Exp.(Inc.), Net-Operating, Total
Unusual Expense (Income)
Other Operating Expenses, Total
Operating Income
Interest Inc.(Exp.),Net-Non-Op.,Total
Gain(Loss) on Sale of Assets
Other, Net
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Minority Interest
Equity in Affiliates
U.S. GAAP Adjustment
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Total Adjustments to Net Income
Income Available to Com Excl ExtraOrd
Income Available to Com Incl ExtraOrd
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Diluted EPS Excluding ExtraOrd Items
Diluted EPS including ExtraOrd Items
DPS – Common Stock Primary Issue
Diluted Normalized EPS
FY 2024
372.81B
372.81B
--
321.41B
51.40B
42.39B
989.00M
--
--
--
1.03B
40.37B
9.01B
-2.96B
--
99.00M
6.15B
1.56B
4.59B
-28.00M
--
--
4.61B
--
4.61B
--
4.61B
4.61B
--
4.61B
1.26B
3.66
3.66
2.66
4.28
FY 2023
357.78B
357.78B
--
303.35B
54.43B
40.69B
985.00M
--
--
--
1.34B
38.36B
13.74B
-2.66B
--
88.00M
11.17B
2.81B
8.37B
24.00M
--
--
8.34B
--
8.34B
--
8.34B
8.34B
--
8.34B
1.29B
6.47
6.47
2.42
7.27
FY 2022
322.47B
322.47B
--
267.96B
54.50B
46.55B
745.00M
--
--
--
8.34B
37.47B
7.95B
-2.29B
--
169.00M
5.84B
1.51B
4.33B
16.00M
--
--
4.31B
--
4.31B
--
4.31B
4.31B
--
4.31B
1.32B
3.26
3.26
2.20
7.93
FY 2021
292.11B
292.11B
--
239.99B
52.12B
39.26B
707.00M
--
--
--
2.37B
36.18B
12.86B
-2.50B
--
182.00M
10.54B
2.55B
7.99B
-12.00M
--
--
8.00B
--
8.00B
--
8.00B
8.00B
--
8.00B
1.33B
6.02
6.02
2.00
7.34
FY 2020
268.71B
268.71B
--
219.66B
49.05B
36.58B
461.00M
--
--
--
1.50B
34.61B
12.47B
-2.91B
--
206.00M
9.77B
2.57B
7.20B
13.00M
--
--
7.19B
-9.00M
7.18B
0.00
7.19B
7.18B
--
7.18B
1.31B
5.47
5.46
2.00
6.31

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.